These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28509605)

  • 1. Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.
    Dubey AP; Faridi MMA; Mitra M; Kaur IR; Dabas A; Choudhury J; Mukherjee M; Mishra D
    Hum Vaccin Immunother; 2017 Sep; 13(9):2032-2037. PubMed ID: 28509605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
    Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
    Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Wittke F; Jotterand V
    Hum Vaccin Immunother; 2021 Nov; 17(11):4183-4189. PubMed ID: 34702124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunogenicity and safety of VARIVAX™ New Seed Process (NSP) in children.
    Senders SD; Bundick ND; Li J; Zecca C; Helmond FA
    Hum Vaccin Immunother; 2018 Feb; 14(2):442-449. PubMed ID: 29087781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Banniettis N
    Hum Vaccin Immunother; 2021 Nov; 17(11):4177-4182. PubMed ID: 34473594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.
    Shinefield HR; Black SB; Staehle BO; Matthews H; Adelman T; Ensor K; Li S; Chan I; Heyse J; Waters M; Chan CY; Vessey SJ; Kaplan KM; Kuter BJ;
    Pediatr Infect Dis J; 2002 Jun; 21(6):555-61. PubMed ID: 12182381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
    Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
    BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
    Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
    J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children.
    Klein NP; Weston WM; Kuriyakose S; Kolhe D; Howe B; Friedland LR; Van Der Meeren O
    Vaccine; 2012 Jan; 30(3):668-74. PubMed ID: 22064267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
    Pan HX; Qiu LX; Liang Q; Chen Z; Zhang ML; Liu S; Zhong GH; Zhu KX; Liao MJ; Hu JL; Li JX; Xu JB; Fan Y; Huang Y; Su YY; Huang SJ; Wang W; Han JL; Jia JZ; Zhu H; Cheng T; Ye XZ; Li CG; Wu T; Zhu FC; Zhang J; Xia NS
    Lancet Infect Dis; 2024 Aug; 24(8):922-934. PubMed ID: 38614117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
    Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, controlled, multi-center safety and immunogenicity study of a refrigerator-stable formulation of VARIVAX®.
    Reisinger KS; Richardson E; Malacaman EA; Levin MJ; Gardner JL; Wang W; Stek JE; Kuter B
    Vaccine; 2019 Sep; 37(38):5788-5795. PubMed ID: 30146405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
    Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
    Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRC.
    Suo L; Lu L; Chen M; Pang X
    BMC Infect Dis; 2015 Nov; 15():509. PubMed ID: 26554449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.